Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer
CONCLUSION: Prominent p62 and LC3 expression in combination with weak Beclin1 expression in high-grade serous carcinoma indicates potential for the application of autophagy inhibitors in patients with this tumor subtype.PMID:36325670 (Source: Croatian Medical Journal)
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Ljubi ša Jovanović Aleksandra Nikoli ć Sandra Dragi čević Milena Jovi ć Radmila Jankovi ć Source Type: research
Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer
CONCLUSION: Prominent p62 and LC3 expression in combination with weak Beclin1 expression in high-grade serous carcinoma indicates potential for the application of autophagy inhibitors in patients with this tumor subtype.PMID:36325670 | PMC:PMC9648085 | DOI:10.3325/cmj.2022.63.453 (Source: Croatian Medical Journal)
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Ljubi ša Jovanović Aleksandra Nikoli ć Sandra Dragi čević Milena Jovi ć Radmila Jankovi ć Source Type: research
Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer
CONCLUSION: Prominent p62 and LC3 expression in combination with weak Beclin1 expression in high-grade serous carcinoma indicates potential for the application of autophagy inhibitors in patients with this tumor subtype.PMID:36325670 (Source: Croatian Medical Journal)
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Ljubi ša Jovanović Aleksandra Nikoli ć Sandra Dragi čević Milena Jovi ć Radmila Jankovi ć Source Type: research
Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer
CONCLUSION: Prominent p62 and LC3 expression in combination with weak Beclin1 expression in high-grade serous carcinoma indicates potential for the application of autophagy inhibitors in patients with this tumor subtype.PMID:36325670 | PMC:PMC9648085 | DOI:10.3325/cmj.2022.63.453 (Source: Croatian Medical Journal)
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Ljubi ša Jovanović Aleksandra Nikoli ć Sandra Dragi čević Milena Jovi ć Radmila Jankovi ć Source Type: research
Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer
CONCLUSION: Prominent p62 and LC3 expression in combination with weak Beclin1 expression in high-grade serous carcinoma indicates potential for the application of autophagy inhibitors in patients with this tumor subtype.PMID:36325670 (Source: Croatian Medical Journal)
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Ljubi ša Jovanović Aleksandra Nikoli ć Sandra Dragi čević Milena Jovi ć Radmila Jankovi ć Source Type: research
Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer
CONCLUSION: Prominent p62 and LC3 expression in combination with weak Beclin1 expression in high-grade serous carcinoma indicates potential for the application of autophagy inhibitors in patients with this tumor subtype.PMID:36325670 (Source: Croatian Medical Journal)
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Ljubi ša Jovanović Aleksandra Nikoli ć Sandra Dragi čević Milena Jovi ć Radmila Jankovi ć Source Type: research
Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer
CONCLUSION: Prominent p62 and LC3 expression in combination with weak Beclin1 expression in high-grade serous carcinoma indicates potential for the application of autophagy inhibitors in patients with this tumor subtype.PMID:36325670 (Source: Croatian Medical Journal)
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Ljubi ša Jovanović Aleksandra Nikoli ć Sandra Dragi čević Milena Jovi ć Radmila Jankovi ć Source Type: research
Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer
CONCLUSION: Prominent p62 and LC3 expression in combination with weak Beclin1 expression in high-grade serous carcinoma indicates potential for the application of autophagy inhibitors in patients with this tumor subtype.PMID:36325670 (Source: Croatian Medical Journal)
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Ljubi ša Jovanović Aleksandra Nikoli ć Sandra Dragi čević Milena Jovi ć Radmila Jankovi ć Source Type: research
Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer
CONCLUSION: Prominent p62 and LC3 expression in combination with weak Beclin1 expression in high-grade serous carcinoma indicates potential for the application of autophagy inhibitors in patients with this tumor subtype.PMID:36325670 (Source: Croatian Medical Journal)
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Ljubi ša Jovanović Aleksandra Nikoli ć Sandra Dragi čević Milena Jovi ć Radmila Jankovi ć Source Type: research
Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer
CONCLUSION: Prominent p62 and LC3 expression in combination with weak Beclin1 expression in high-grade serous carcinoma indicates potential for the application of autophagy inhibitors in patients with this tumor subtype.PMID:36325670 (Source: Croatian Medical Journal)
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Ljubi ša Jovanović Aleksandra Nikoli ć Sandra Dragi čević Milena Jovi ć Radmila Jankovi ć Source Type: research
Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer
CONCLUSION: Prominent p62 and LC3 expression in combination with weak Beclin1 expression in high-grade serous carcinoma indicates potential for the application of autophagy inhibitors in patients with this tumor subtype.PMID:36325670 (Source: Croatian Medical Journal)
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Ljubi ša Jovanović Aleksandra Nikoli ć Sandra Dragi čević Milena Jovi ć Radmila Jankovi ć Source Type: research
Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer
CONCLUSION: Prominent p62 and LC3 expression in combination with weak Beclin1 expression in high-grade serous carcinoma indicates potential for the application of autophagy inhibitors in patients with this tumor subtype.PMID:36325670 (Source: Croatian Medical Journal)
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Ljubi ša Jovanović Aleksandra Nikoli ć Sandra Dragi čević Milena Jovi ć Radmila Jankovi ć Source Type: research
Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer
CONCLUSION: Prominent p62 and LC3 expression in combination with weak Beclin1 expression in high-grade serous carcinoma indicates potential for the application of autophagy inhibitors in patients with this tumor subtype.PMID:36325670 | PMC:PMC9648085 | DOI:10.3325/cmj.2022.63.453 (Source: Croatian Medical Journal)
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Ljubi ša Jovanović Aleksandra Nikoli ć Sandra Dragi čević Milena Jovi ć Radmila Jankovi ć Source Type: research
Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer
CONCLUSION: Prominent p62 and LC3 expression in combination with weak Beclin1 expression in high-grade serous carcinoma indicates potential for the application of autophagy inhibitors in patients with this tumor subtype.PMID:36325670 (Source: Croatian Medical Journal)
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Ljubi ša Jovanović Aleksandra Nikoli ć Sandra Dragi čević Milena Jovi ć Radmila Jankovi ć Source Type: research
Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer
CONCLUSION: Prominent p62 and LC3 expression in combination with weak Beclin1 expression in high-grade serous carcinoma indicates potential for the application of autophagy inhibitors in patients with this tumor subtype.PMID:36325670 | PMC:PMC9648085 | DOI:10.3325/cmj.2022.63.453 (Source: Croatian Medical Journal)
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Ljubi ša Jovanović Aleksandra Nikoli ć Sandra Dragi čević Milena Jovi ć Radmila Jankovi ć Source Type: research
